Chairman Michael J. Farrell - 11 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role
Chairman and CEO, Director
Signature
/s/ Mike J. Rider, attorney-in-fact for Mr. Farrell
Issuer symbol
RMD
Transactions as of
11 Nov 2025
Net transactions value
-$1,974,931
Form type
4
Filing time
13 Nov 2025, 17:37:19 UTC
Previous filing
10 Nov 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Farrell Michael J. Chairman and CEO, Director RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO /s/ Mike J. Rider, attorney-in-fact for Mr. Farrell 13 Nov 2025 0001485164

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $558,109 -2,232 -0.48% $250.10 465,634 11 Nov 2025 Direct F1
transaction RMD ResMed Common Stock Tax liability $865,177 -3,459 -0.74% $250.10 462,175 11 Nov 2025 Direct F2
transaction RMD ResMed Common Stock Tax liability $551,645 -2,206 -0.48% $250.10 459,969 11 Nov 2025 Direct F3
holding RMD ResMed Common Stock 2,090 11 Nov 2025 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2024.